Kohn L D, Winand R J, Bates R W
Endocrinology. 1975 May;96(5):1329-32. doi: 10.1210/endo-96-5-1329.
The present report demonstrates that mouse tumor thyrotropin preprarations have exophthalmogenic activity. In addition it shows that the exophthalmogenic activity of mouse tumor thyrotropin can be increased by partial pepsin digestion, whereas the thyroid stimulating activity of mouse tumor thyrotropin is rapidly destroyed by such treatment. Thus, after 30 min of pepsin digestion, mouse tumor thyrotropin has 130% of its initial exophthalmogenic action but only 10% of its thyroid stimulating activity. Preparations of human thyrotropin are similarly sensitive to partial pepsin digestion, i.e., there is a rapid destruction of thyroid stimulating activity but a very much slower destruction of exophthalmogenic activity. Thus, after 30 min of pepsin digestion, preparations of human thyrotropin retain 80% of their exophthalmogenic activity but only 20-30% of their thyroid stimulating action. Since these results are analogous to those obtained in studies of the partial pepsin digestion of bovine thyrotropin (1), partial pepsin digestion of both purified human and purified mouse tumor thyrotropin preparations should yield an exophthalmogenic fragment of the TSH molecule devoid of thyroid stimulating action.
本报告表明,小鼠肿瘤促甲状腺激素制剂具有致突眼活性。此外,研究还显示,小鼠肿瘤促甲状腺激素的致突眼活性可通过胃蛋白酶部分消化而增强,而小鼠肿瘤促甲状腺激素的甲状腺刺激活性经此处理后会迅速被破坏。因此,胃蛋白酶消化30分钟后,小鼠肿瘤促甲状腺激素的初始致突眼活性为130%,但其甲状腺刺激活性仅为初始的10%。人促甲状腺激素制剂对胃蛋白酶部分消化同样敏感,即甲状腺刺激活性迅速被破坏,但致突眼活性的破坏则要慢得多。因此,胃蛋白酶消化30分钟后,人促甲状腺激素制剂仍保留80%的致突眼活性,但其甲状腺刺激活性仅为初始的20 - 30%。由于这些结果与牛促甲状腺激素胃蛋白酶部分消化研究所得结果相似(1),对纯化的人促甲状腺激素制剂和纯化的小鼠肿瘤促甲状腺激素制剂进行胃蛋白酶部分消化,均应产生一种无甲状腺刺激作用的促甲状腺激素分子致突眼片段。